Biocompatibility Documentation Consulting
Biocompatibility Documentation Consulting to ISO 10993
Independent Biocompatibility Consultants
MDRcert writes and remediates biological evaluation documentation for medical device manufacturers under ISO 10993. We are consultants, not a test laboratory, and we do not run the studies ourselves. We design the evaluation strategy, interpret the data, and author the file the laboratory's results go into.
Biocompatibility is a documented evaluation, not a test panel run by habit. ISO 10993-1:2018 requires a biological evaluation plan built from the device's nature and duration of body contact, using the contact categorisation in its Annex A, before any test is selected. A test matrix chosen first and justified afterward is a common and avoidable deficiency.
MDR Annex I GSPR 10.1 and 10.4.1 require biological safety to be demonstrated for the specific device, materials and manufacturing process, which is why a biocompatibility file built for a similar device rarely transfers cleanly.
Biological Evaluation Reports That Argue, Not Assert
The most common deficiency is a Biological Evaluation Report that lists endpoint results without connecting them to a documented risk-based rationale. A green result table with no argument behind it does not satisfy a reviewer who is applying ISO 10993-1's endpoint decision logic themselves.
Chemical characterization under ISO 10993-18:2020 has become the pivot point of most evaluations. Under the toxicological risk assessment approach in ISO 10993-17, thorough chemical characterization can justify reducing or replacing biological endpoint testing, which frequently saves both time and animal use. Skipping it and defaulting straight to a full test battery is usually the more expensive path, not the safer one.
We build the plan first, generate or source the right evidence for each endpoint, and write the report as an argument: contact category, applicable endpoints, available data, gaps, and the toxicological reasoning that closes them.
Assess
Material, Device Contact and Gap Assessment
Plan
ISO 10993 Endpoint Strategy and Test Planning
Build
Data Generation, Literature and Toxicological Assessment
Submit
Biological Evaluation Report Compilation
Maintain
Deficiency Response and Lifecycle Update Support
What teams need before biocompatibility review
Most biocompatibility files fail for one of two reasons: the contact category was assigned incorrectly, so the wrong endpoint set was tested, or the report never connects the endpoint data back to a stated risk-based rationale.
We start with categorisation, because ISO 10993-1 Annex A decides which endpoints apply based on contact nature, duration and whether the device is implantable, and getting this wrong invalidates the entire test matrix built on top of it. Chemical characterization under ISO 10993-18 comes next, since it frequently reduces the biological testing that would otherwise be required. The resulting evaluation is aligned with the ISO 14971 risk management file, because biological risk is one input into the overall risk-benefit picture, not a separate silo.
Where a material or manufacturing change has occurred, the question is not whether new testing is needed by default, but whether the existing evaluation still covers the change. Our MDR consulting service covers how that decision feeds the wider technical file.
Facing a biocompatibility deficiency or a new device evaluation?
Core Biocompatibility Documentation Coverage
Testimonials
Working with MDRCert for our MDR compliance audit was a game-changer. Their thorough risk management assessment helped us achieve Notified Body approval on the ...
Dr. James Rodriguez
MDRCert guided us through our complete IVDR transition with exceptional expertise. Their team identified critical gaps in our technical documentation and provid...
Sarah David
As a first-time manufacturer, the EU MDR felt overwhelming. MDRCert became our trusted partner, guiding us from initial strategy and risk management to final su...
Ben Smith
The gap analysis conducted by MDRCert was a game-changer. They identified critical vulnerabilities in our technical file before our notified body audit. Their a...
Thomas Wright
Implementing a compliant ISO 13485:2016 QMS seemed daunting. MDRCert provided clear, pragmatic guidance tailored to our small company’s needs. They didn&#...
Maria Rodriguez
MDRCert authored a comprehensive Clinical Evaluation Report for our Class IIb device. Their report was exceptionally thorough and meticulously structured, which...
David Chen
We engaged MDRCert for our full MDR transition strategy. Their team’s deep expertise, particularly their former notified body background, was invaluable. ...
Sarah Jenkins
Frequently Asked Questions About Biocompatibility Documentation
These are the questions manufacturers most often ask before starting a biocompatibility evaluation or responding to a Notified Body query. For the full range of regulatory support we offer, see our consulting services.
Need a clear path to compliance? Talk to MDRCert
Tell us about your device, target market, and current stage. We will guide you on the most practical next steps.
MDRCert Regulatory Support Team
Have questions? Contact our team
Still have questions?
Can't find the answer you're looking for? Contact our expert team today.
